Clinical Trial Details
| Trial ID: | L4692 |
| Source ID: | NCT01017302 |
| Associated Drug: | Placebo |
| Title: | A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy. |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus Type 2 |
| Interventions: | DRUG: Placebo|DRUG: Placebo|DRUG: RO5095932|DRUG: RO5095932 |
| Outcome Measures: | Primary: Safety and Tolerability of various doses of RO5095932, Weeks 1-4, 6, 8 | Secondary: Safety and Tolerability of a single dose of RO5095932, Week 5, 6, 8|Pharmacokinetics: blood concentration, Weeks 1-4, 6, 8|Pharmacodynamics: glucose, insulin, C-peptide, Weeks 1-4, 6, 8 |
| Sponsor/Collaborators: | Sponsor: Hoffmann-La Roche |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 32 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2009-12 |
| Completion Date: | 2011-08 |
| Results First Posted: | |
| Last Update Posted: | 2016-11-02 |
| Locations: | San Antonio, Texas, 78229, United States |
| URL: | https://clinicaltrials.gov/show/NCT01017302 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|